TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - The blockade of immune checkpoints in cancer immunotherapy JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3239 DO - 10.1038/nrc3239 ID - Pardoll2012 ER - TY - JOUR AU - Nishimura, H. AU - Nose, M. AU - Hiai, H. AU - Minato, N. AU - Honjo, T. PY - 1999 DA - 1999// TI - Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor JO - Immunity. VL - 11 UR - https://doi.org/10.1016/S1074-7613(00)80089-8 DO - 10.1016/S1074-7613(00)80089-8 ID - Nishimura1999 ER - TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - Immunology beats cancer: a blueprint for successful translation JO - Nat Immunol VL - 13 UR - https://doi.org/10.1038/ni.2392 DO - 10.1038/ni.2392 ID - Pardoll2012 ER - TY - JOUR AU - Honda, Y. AU - Otsuka, A. AU - Ono, S. AU - Yamamoto, Y. AU - Seidel, J. A. AU - Morita, S. PY - 2017 DA - 2017// TI - Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2016.1253657 DO - 10.1080/2162402X.2016.1253657 ID - Honda2017 ER - TY - JOUR AU - Abiko, K. AU - Mandai, M. AU - Hamanishi, J. AU - Yoshioka, Y. AU - Matsumura, N. AU - Baba, T. PY - 2013 DA - 2013// TI - PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2199 DO - 10.1158/1078-0432.CCR-12-2199 ID - Abiko2013 ER - TY - JOUR AU - Mandai, M. AU - Hamanishi, J. AU - Abiko, K. AU - Matsumura, N. AU - Baba, T. AU - Konishi, I. PY - 2016 DA - 2016// TI - Dual faces of IFNgamma in cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-16-0224 DO - 10.1158/1078-0432.CCR-16-0224 ID - Mandai2016 ER - TY - JOUR AU - Dong, H. AU - Strome, S. E. AU - Salomao, D. R. AU - Tamura, H. AU - Hirano, F. AU - Flies, D. B. PY - 2002 DA - 2002// TI - Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion JO - Nat Med VL - 8 UR - https://doi.org/10.1038/nm730 DO - 10.1038/nm730 ID - Dong2002 ER - TY - JOUR AU - Malas, S. AU - Harrasser, M. AU - Lacy, K. E. AU - Karagiannis, S. N. PY - 2014 DA - 2014// TI - Antibody therapies for melanoma: new and emerging opportunities to activate immunity (review) JO - Oncol Rep VL - 32 UR - https://doi.org/10.3892/or.2014.3275 DO - 10.3892/or.2014.3275 ID - Malas2014 ER - TY - JOUR AU - Pillai, R. N. AU - Behera, M. AU - Owonikoko, T. K. AU - Kamphorst, A. O. AU - Pakkala, S. AU - Belani, C. P. PY - 2018 DA - 2018// TI - Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: a systematic analysis of the literature JO - Cancer. VL - 124 UR - https://doi.org/10.1002/cncr.31043 DO - 10.1002/cncr.31043 ID - Pillai2018 ER - TY - JOUR AU - You, W. AU - Liu, M. AU - Miao, J. D. AU - Liao, Y. Q. AU - Song, Y. B. AU - Cai, D. K. PY - 2018 DA - 2018// TI - A network meta-analysis comparing the efficacy and safety of anti-PD-1 with anti-PD-L1 in non-small cell lung cancer JO - J Cancer VL - 9 UR - https://doi.org/10.7150/jca.22361 DO - 10.7150/jca.22361 ID - You2018 ER - TY - JOUR AU - Zheng, Y. AU - Rudensky, A. Y. PY - 2007 DA - 2007// TI - Foxp3 in control of the regulatory T cell lineage JO - Nat Immunol VL - 8 UR - https://doi.org/10.1038/ni1455 DO - 10.1038/ni1455 ID - Zheng2007 ER - TY - JOUR AU - Quezada, S. A. AU - Simpson, T. R. AU - Peggs, K. S. AU - Merghoub, T. AU - Vider, J. AU - Fan, X. PY - 2010 DA - 2010// TI - Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20091918 DO - 10.1084/jem.20091918 ID - Quezada2010 ER - TY - JOUR AU - Selby, M. J. AU - Engelhardt, J. J. AU - Quigley, M. AU - Henning, K. A. AU - Chen, T. AU - Srinivasan, M. PY - 2013 DA - 2013// TI - Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0013 DO - 10.1158/2326-6066.CIR-13-0013 ID - Selby2013 ER - TY - JOUR AU - Miyara, M. AU - Yoshioka, Y. AU - Kitoh, A. AU - Shima, T. AU - Wing, K. AU - Niwa, A. PY - 2009 DA - 2009// TI - Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor JO - Immunity. VL - 30 UR - https://doi.org/10.1016/j.immuni.2009.03.019 DO - 10.1016/j.immuni.2009.03.019 ID - Miyara2009 ER - TY - JOUR AU - Park, H. J. AU - Park, J. S. AU - Jeong, Y. H. AU - Son, J. AU - Ban, Y. H. AU - Lee, B. H. PY - 2015 DA - 2015// TI - PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells JO - J Immunol VL - 194 UR - https://doi.org/10.4049/jimmunol.1401936 DO - 10.4049/jimmunol.1401936 ID - Park2015 ER - TY - JOUR AU - Asano, T. a. k. e. r. u. AU - Meguri, Y. u. s. u. k. e. AU - Yoshioka, T. a. k. a. n. o. r. i. AU - Kishi, Y. u. r. i. k. o. AU - Iwamoto, M. i. k. i. AU - Nakamura, M. a. k. o. t. o. AU - Sando, Y. a. s. u. h. i. s. a. AU - Yagita, H. i. d. e. o. AU - Koreth, J. o. h. n. AU - Kim, H. a. e. s. o. o. k. T. AU - Alyea, E. d. w. i. n. P. AU - Armand, P. h. i. l. i. p. p. e. AU - Cutler, C. o. r. e. y. S. AU - Ho, V. i. n. c. e. n. t. T. AU - Antin, J. o. s. e. p. h. H. AU - Soiffer, R. o. b. e. r. t. J. AU - Maeda, Y. o. s. h. i. n. o. b. u. AU - Tanimoto, M. i. t. s. u. n. e. AU - Ritz, J. e. r. o. m. e. AU - Matsuoka, K. e. n. -. i. c. h. i. PY - 2017 DA - 2017// TI - PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy JO - Blood VL - 129 UR - https://doi.org/10.1182/blood-2016-09-741629 DO - 10.1182/blood-2016-09-741629 ID - Asano2017 ER - TY - JOUR AU - Zhang, B. AU - Chikuma, S. AU - Hori, S. AU - Fagarasan, S. AU - Honjo, T. PY - 2016 DA - 2016// TI - Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model JO - Proc Natl Acad Sci U S A VL - 113 UR - https://doi.org/10.1073/pnas.1608873113 DO - 10.1073/pnas.1608873113 ID - Zhang2016 ER - TY - JOUR AU - Gianchecchi, E. AU - Fierabracci, A. PY - 2018 DA - 2018// TI - Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in treg development and their involvement in autoimmunity onset and cancer progression JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.02374 DO - 10.3389/fimmu.2018.02374 ID - Gianchecchi2018 ER - TY - JOUR AU - Kamada, T. AU - Togashi, Y. AU - Tay, C. AU - Ha, D. AU - Sasaki, A. AU - Nakamura, Y. PY - 2019 DA - 2019// TI - PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer JO - Proc Natl Acad Sci VL - 116 ID - Kamada2019 ER - TY - JOUR AU - Tawbi, H. A. AU - Burgess, M. AU - Bolejack, V. AU - Tine, B. A. AU - Schuetze, S. M. AU - Hu, J. PY - 2017 DA - 2017// TI - Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial JO - Lancet Oncol VL - 18 UR - https://doi.org/10.1016/S1470-2045(17)30624-1 DO - 10.1016/S1470-2045(17)30624-1 ID - Tawbi2017 ER - TY - JOUR AU - Burgess, M. A. AU - Crowley, J. AU - Reinke, D. K. AU - Riedel, R. F. AU - George, S. AU - Movva, S. PY - 2015 DA - 2015// TI - SARC 028: a phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/jco.2015.33.15_suppl.tps10578 DO - 10.1200/jco.2015.33.15_suppl.tps10578 ID - Burgess2015 ER - TY - JOUR AU - Paoluzzi, L. AU - Cacavio, A. AU - Ghesani, M. AU - Karambelkar, A. AU - Rapkiewicz, A. AU - Weber, J. PY - 2016 DA - 2016// TI - Response to anti-PD1 therapy with nivolumab in metastatic sarcomas JO - Clin Sarcoma Res VL - 6 UR - https://doi.org/10.1186/s13569-016-0064-0 DO - 10.1186/s13569-016-0064-0 ID - Paoluzzi2016 ER - TY - JOUR AU - Zheng, B. AU - Ren, T. AU - Huang, Y. AU - Sun, K. AU - Wang, S. AU - Bao, X. PY - 2018 DA - 2018// TI - PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-018-0560-1 DO - 10.1186/s13045-018-0560-1 ID - Zheng2018 ER - TY - JOUR AU - Shen, J. K. AU - Cote, G. M. AU - Choy, E. AU - Yang, P. AU - Harmon, D. AU - Schwab, J. PY - 2014 DA - 2014// TI - Programmed cell death ligand 1 expression in osteosarcoma JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-13-0224 DO - 10.1158/2326-6066.CIR-13-0224 ID - Shen2014 ER - TY - JOUR AU - Wedekind, M. F. AU - Wagner, L. M. AU - Cripe, T. P. PY - 2018 DA - 2018// TI - Immunotherapy for osteosarcoma: where do we go from here? JO - Pediatr Blood Cancer VL - 65 UR - https://doi.org/10.1002/pbc.27227 DO - 10.1002/pbc.27227 ID - Wedekind2018 ER - TY - JOUR AU - Erp, A. E. M. AU - Versleijen-Jonkers, Y. M. H. AU - Hillebrandt-Roeffen, M. H. S. AU - Houdt, L. AU - Gorris, M. A. J. AU - Dam, L. S. PY - 2017 DA - 2017// TI - Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8(+) lymphocytes in primary sarcomas is subtype dependent JO - Oncotarget. VL - 8 ID - Erp2017 ER - TY - JOUR AU - Gomez-Brouchet, A. AU - Illac, C. AU - Gilhodes, J. AU - Bouvier, C. AU - Aubert, S. AU - Guinebretiere, J. M. PY - 2017 DA - 2017// TI - CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: an immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1331193 DO - 10.1080/2162402X.2017.1331193 ID - Gomez-Brouchet2017 ER - TY - JOUR AU - Workman, P. AU - Aboagye, E. O. AU - Balkwill, F. AU - Balmain, A. AU - Bruder, G. AU - Chaplin, D. J. PY - 2010 DA - 2010// TI - Guidelines for the welfare and use of animals in cancer research JO - Br J Cancer VL - 102 UR - https://doi.org/10.1038/sj.bjc.6605642 DO - 10.1038/sj.bjc.6605642 ID - Workman2010 ER - TY - JOUR AU - Ratti, C. AU - Botti, L. AU - Cancila, V. AU - Galvan, S. AU - Torselli, I. AU - Garofalo, C. PY - 2017 DA - 2017// TI - Trabectedin overrides osteosarcoma differentiative block and reprograms the tumor immune environment enabling effective combination with immune checkpoint inhibitors JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-3186 DO - 10.1158/1078-0432.CCR-16-3186 ID - Ratti2017 ER - TY - JOUR AU - Maciorowski, Z. AU - Chattopadhyay, P. K. AU - Jain, P. PY - 2017 DA - 2017// TI - Basic multicolor flow cytometry JO - Curr Protoc Immunol VL - 117 UR - https://doi.org/10.1002/cpim.26 DO - 10.1002/cpim.26 ID - Maciorowski2017 ER - TY - JOUR AU - Xiao, Q. AU - Wu, J. AU - Wang, W. J. AU - Chen, S. AU - Zheng, Y. AU - Yu, X. PY - 2018 DA - 2018// TI - DKK2 imparts tumor immunity evasion through beta-catenin-independent suppression of cytotoxic immune-cell activation JO - Nat Med VL - 24 UR - https://doi.org/10.1038/nm.4496 DO - 10.1038/nm.4496 ID - Xiao2018 ER - TY - JOUR AU - Parsa, A. T. AU - Waldron, J. S. AU - Panner, A. AU - Crane, C. A. AU - Parney, I. F. AU - Barry, J. J. PY - 2007 DA - 2007// TI - Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1517 DO - 10.1038/nm1517 ID - Parsa2007 ER - TY - JOUR AU - Marzec, M. AU - Zhang, Q. AU - Goradia, A. AU - Raghunath, P. N. AU - Liu, X. AU - Paessler, M. PY - 2008 DA - 2008// TI - Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1) JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0810958105 DO - 10.1073/pnas.0810958105 ID - Marzec2008 ER - TY - JOUR AU - Alsaab, H. O. AU - Sau, S. AU - Alzhrani, R. AU - Tatiparti, K. AU - Bhise, K. AU - Kashaw, S. K. PY - 2017 DA - 2017// TI - PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome JO - Front Pharmacol VL - 8 UR - https://doi.org/10.3389/fphar.2017.00561 DO - 10.3389/fphar.2017.00561 ID - Alsaab2017 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. AU - Shintaku, I. P. AU - Taylor, E. J. AU - Robert, L. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature. VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - JOUR AU - Sun, C. AU - Mezzadra, R. AU - Schumacher, T. N. PY - 2018 DA - 2018// TI - Regulation and function of the PD-L1 checkpoint JO - Immunity. VL - 48 UR - https://doi.org/10.1016/j.immuni.2018.03.014 DO - 10.1016/j.immuni.2018.03.014 ID - Sun2018 ER - TY - JOUR AU - Liakou, C. I. AU - Kamat, A. AU - Tang, D. N. AU - Chen, H. AU - Sun, J. AU - Troncoso, P. PY - 2008 DA - 2008// TI - CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0806075105 DO - 10.1073/pnas.0806075105 ID - Liakou2008 ER - TY - JOUR AU - Zuazo, M. AU - Arasanz, H. AU - Fernández-Hinojal, G. AU - García-Granda, M. J. AU - Gato, M. AU - Bocanegra, A. PY - 2019 DA - 2019// TI - Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy JO - EMBO Mol Med VL - 11 UR - https://doi.org/10.15252/emmm.201910293 DO - 10.15252/emmm.201910293 ID - Zuazo2019 ER - TY - JOUR AU - Josefowicz, S. Z. AU - Lu, L. -. F. AU - Rudensky, A. Y. PY - 2012 DA - 2012// TI - Regulatory T cells: mechanisms of differentiation and function JO - Annu Rev Immunol VL - 30 UR - https://doi.org/10.1146/annurev.immunol.25.022106.141623 DO - 10.1146/annurev.immunol.25.022106.141623 ID - Josefowicz2012 ER - TY - JOUR AU - Callahan, M. K. AU - Wolchok, J. D. AU - Allison, J. P. PY - 2010 DA - 2010// TI - Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy JO - Semin Oncol VL - 37 UR - https://doi.org/10.1053/j.seminoncol.2010.09.001 DO - 10.1053/j.seminoncol.2010.09.001 ID - Callahan2010 ER - TY - JOUR AU - Simpson, T. R. AU - Li, F. AU - Montalvo-Ortiz, W. AU - Sepulveda, M. A. AU - Bergerhoff, K. AU - Arce, F. PY - 2013 DA - 2013// TI - Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma JO - J Exp Med VL - 210 UR - https://doi.org/10.1084/jem.20130579 DO - 10.1084/jem.20130579 ID - Simpson2013 ER - TY - JOUR AU - Takeuchi, Y. AU - Nishikawa, H. PY - 2016 DA - 2016// TI - Roles of regulatory T cells in cancer immunity JO - Int Immunol VL - 28 UR - https://doi.org/10.1093/intimm/dxw025 DO - 10.1093/intimm/dxw025 ID - Takeuchi2016 ER -